Accendra HealthACH +2.24%57 EBITDA Margin % is 12.40% as of Mar. 2026, which is 313% above its 10-year median of 3.00. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 119 Medical Distribution companies, Accendra Health ranks better than 69.75% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Accendra Health's EBITDA for the
three
months ended in Mar. 2026 was $78 Mil. Accendra Health's Revenue for the
three
months ended in Mar. 2026 was $628 Mil. Therefore, Accendra Health's EBITDA margin for the quarter that ended in Mar. 2026 was 12.40%.
Accendra Health (NYSE:ACH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Accendra Health EBITDA Margin % Related Terms
Accendra Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Accendra Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Accendra Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a EBITDA Margin % of 12.40% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Accendra Health and its competitors. This is 313% above median its historical median of 3.00. According to the industry distribution chart, Accendra Health ranks #36 out of 119 companies in the Medical Distribution industry, placing it in the top 30.3%.
Is Accendra Health's EBITDA Margin % too high?
Accendra Health's current EBITDA Margin % of 12.40% is 313% above median its 10-year median of 3.00. The Medical Distribution industry median EBITDA Margin % is 4.31. Accendra Health's value of 12.40% is 187.7% above this industry median. Based on the distribution chart, Accendra Health ranks #36 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's EBITDA Margin % compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #36 out of 119 companies for EBITDA Margin %. This puts Accendra Health in the upper half of its industry. The industry median EBITDA Margin % is 4.31. Accendra Health's value of 12.40% is 187.7% above this benchmark. While the company's 10-year median is 3.00 vs. the industry median of 4.31, Accendra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current EBITDA Margin % of 12.40% is 187.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current EBITDA Margin % is 12.40%, which is 313% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current EBITDA Margin % is 12.40%, which is 313% above median its 10-year median of 3.00 and 187.7% above the Medical Distribution industry median of 4.31. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Accendra Health (ACH), the current EBITDA Margin % is 12.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
EBITDA Margin %: 12.40% (313% above median its 10-year median of 3.00)
GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
Industry Position: 187.7% above the Medical Distribution median (#36 of 119)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
